Immunological Data Discovery Index
Advanced Search
identifier: 1327533
description:
epitope description:beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)]-alpha-D-Araf-(1->5)-alpha-D-Araf-yl group
antigen name:lipoarabinomannan
host organism:Mus musculus
antibody name:CS-35
aggregation:
instance of dataset
availability:
available
primaryPublications: 12368438
authorizations:
registration not required
accessURL: http://www.iedb.org/reference/1002169
landingPage: http://www.iedb.org/assay/1327533
type:
Literature
publicationVenue:
Microbiology
dates:
2002
study type: b cell assays
subject species: Mycobacterium leprae
fullName:
Devinder Kaur
Todd L Lowary
Varalakshmi D Vissa
Dean C Crick
Patrick J Brennan
method:
antigen inhibition
name:
Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans.
description:
This structure constitutes the hexaarabinofuranosyl termini of the arabinan as found in mycolylarabinogalactan-peptidoglycan complex and lipoarabinomannan of the mycobacterial cell wall. The lipoarabinomannan used in this study was isolated from the from M.smegmatis, while the one used for immunizations was from M.leprae.
The synthetic Hexa-Araf oligosaccharide is able to inhibit the binding of the anti-LAM mAb CS-35 to Arabinogalactan (AG). The tetrasaccharides that represent the linear segments of this epitope (without either branch) are less or non-effective, implying the full hexasaccharide is involved in recognition. LAM itself is also a good inhibitor.

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on Feedback.